Zentalis Pharmaceuticals (ZNTL) Change in Cash (2019 - 2026)

Zentalis Pharmaceuticals' Change in Cash history runs 8 years deep, the most recent figure standing at -$4.1 million for Q1 2026.

• In Q1 2026, Change in Cash fell 150.64% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at -$10.0 million (down 334.77% YoY), while the FY2025 annual figure was $2.1 million, down 63.95% from the prior year.
• Change in Cash was -$4.1 million for Q1 2026 at Zentalis Pharmaceuticals, down from -$3.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $230.3 million in Q2 2023 to a low of -$155.8 million in Q3 2023.
• Historically, Change in Cash has averaged -$1.6 million across 5 years, with a median of -$3.1 million in 2025.
• Biggest YoY gain for Change in Cash was 846.56% in 2023; the steepest drop was 16057.34% in 2023.
• A 5-year view of Change in Cash shows it stood at $518000.0 in 2022, then tumbled by 16057.34% to -$82.7 million in 2023, then jumped by 91.02% to -$7.4 million in 2024, then jumped by 58.53% to -$3.1 million in 2025, then plunged by 32.11% to -$4.1 million in 2026.
• The last three Change in Cash figures came in at -$4.1 million (Q1 2026), -$3.1 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.